| Literature DB >> 29755700 |
Pradeep Sharma1, Sunil Maherchandani1, B N Shringi1, Sudhir Kumar Kashyap1, K S Gopi Sundar2,3.
Abstract
Aims: Multiple antimicrobial resistance in Escherichia coli of wild vertebrates is a global concern with scarce assessments on the subject from developing countries that have high human-wild species interactions. We studied the ecology of E. coli in a wintering population of Egyptian Vultures in India to understand temporal changes in both E. coli strains and patterns of antimicrobial resistance. Methods andEntities:
Keywords: Antimicrobial resistance; Egyptian vulture; Escherichia coli; carcass dump; microbial ecology
Year: 2018 PMID: 29755700 PMCID: PMC5941391 DOI: 10.1080/20008686.2018.1450590
Source DB: PubMed Journal: Infect Ecol Epidemiol ISSN: 2000-8686
Sampling periods and frequency of isolation of the E. coli.
| Month and year of sampling | No. of samples | Frequency of isolation of | Frequency of isolation (in percent) |
|---|---|---|---|
| February, 2011 | 13 | 12 | 92.31 |
| October, 2011 | 13 | 12 | 92.31 |
| November, 2011 | 21 | 19 | 90.48 |
| March, 2012 | 15 | 13 | 86.67 |
| Total | 62 | 56 | 90.32 |
Figure 1.Scatterplot from discriminant analysis of principal components (DAPC) of the first two principal components discriminating E. coli communities colour-coded by month (F – February; O – October; N – November; M – March) across two wintering periods (1 – 2010-2011; 2 – 2011-2012). Each point represents actual data, and lines represent each population’s membership. Ellipses represent 67% confidence intervals based on a bivariate normal distribution. Number of principal components at which the maximal reassignment of samples occurred are depicted as black lines the PCA graph on the top-left corner, with subsequent components in grey line.
Antimicrobial resistance pattern of the E. coli in four sampling efforts.
| Sr No. | Name of Antimicrobial | Response of the | February, 2011 | October, 2011 | November, 2011 | March, 2012 | Overall |
|---|---|---|---|---|---|---|---|
| 1 | Ampicillin | Sensitive | 0.00 | 0.00 | 0.00 | 7.69 | 1.79 |
| Intermediate | 33.33 | 0.00 | 0.00 | 0.00 | 7.14 | ||
| Resistance | 66.67 | 100.00 | 100.00 | 92.31 | 91.07 | ||
| 2 | Gentamicin | Sensitive | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Resistance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| 3 | Imipenem | Sensitive | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Resistance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| 4 | Ampicillin+ | Sensitive | 100.00 | 83.33 | 68.42 | 53.85 | 75.00 |
| Intermediate | 0.00 | 0.00 | 21.05 | 46.15 | 17.86 | ||
| Resistance | 0.00 | 16.67 | 10.53 | 0.00 | 7.14 | ||
| 5 | Cephotaxime | Sensitive | 0.00 | 91.67 | 42.11 | 53.85 | 46.43 |
| Intermediate | 0.00 | 0.00 | 52.63 | 0.00 | 17.86 | ||
| Resistance | 100.00 | 8.33 | 5.26 | 46.15 | 35.71 | ||
| 6 | Cefepime | Sensitive | 0.00 | 91.67 | 78.95 | 84.62 | 66.07 |
| Intermediate | 25.00 | 0.00 | 5.26 | 15.38 | 10.71 | ||
| Resistance | 75.00 | 8.33 | 15.79 | 0.00 | 23.21 | ||
| 7 | Ofloxacin | Sensitive | 75.00 | 91.67 | 47.37 | 69.23 | 67.86 |
| Intermediate | 0.00 | 0.00 | 21.05 | 7.69 | 8.93 | ||
| Resistance | 25.00 | 8.33 | 31.58 | 23.08 | 23.21 | ||
| 8 | Erythromycin | Sensitive | 0.00 | 0.00 | 47.37 | 0.00 | 16.07 |
| Intermediate | 0.00 | 50.00 | 0.00 | 53.85 | 23.21 | ||
| Resistance | 100.00 | 50.00 | 52.63 | 46.15 | 60.71 | ||
| 9 | Co-trimoxazole | Sensitive | 58.33 | 75.00 | 73.68 | 53.85 | 66.07 |
| Intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Resistance | 41.67 | 25.00 | 26.32 | 46.15 | 33.93 | ||
| 10 | Rifampicin | Sensitive | 91.67 | 58.33 | 73.68 | 53.85 | 69.64 |
| Intermediate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Resistance | 8.33 | 41.67 | 26.32 | 46.15 | 30.36 | ||
| 11 | Chloramphenicol | Sensitive | 100.00 | 83.33 | 78.95 | 100.00 | 89.29 |
| Intermediate | 0.00 | 0.00 | 5.26 | 0.00 | 1.79 | ||
| Resistance | 0.00 | 16.67 | 15.79 | 0.00 | 8.93 | ||
| 12 | Ciprofloxacin | Sensitive | 66.67 | 83.33 | 52.63 | 46.15 | 60.71 |
| Intermediate | 8.33 | 8.33 | 10.53 | 38.46 | 16.07 | ||
| Resistance | 25.00 | 8.33 | 36.84 | 15.38 | 23.21 | ||
| 13 | Tetracyclin | Sensitive | 41.67 | 16.67 | 10.53 | 7.69 | 17.86 |
| Intermediate | 16.67 | 41.67 | 31.58 | 7.69 | 25.00 | ||
| Resistance | 41.67 | 41.67 | 57.89 | 84.62 | 57.14 |
Figure 2.Non-metric multidimensional scaling (NMDS) plot representing resistance to varied antimicriobials by E. coli in Egyptian vultures across different months (F – February; O – October; N – November; M – March) in two-dimensional space.
Pair-wise comparisons of dissimilarity in E. coli ribotypes in a wintering Egyptian Vulture population in Jorbeer using Jaccard’s index. (* – P < 0.05; n.s. – not significant).
| October 2011 | November 2011 | March 2012 | |
|---|---|---|---|
| February 2011 | n.s. | * | * |
| October 2011 | * | n.s. | |
| November 2011 | * |
Results of the indicator species analyses showing antimicrobials with temporal variation more than by random chance in (a) single months, and (b) multiple months.
| A. Single-antimicrobial, single-month (Indicator values, with | |||||
|---|---|---|---|---|---|
| Antimicrobial | February, 2011 | October, 2011 | November, 2011 | March, 2012 | |
| Cephotaxime | 0.602 (0.015) | ||||
| Cefepime | 0.596 (0.015) | ||||
| Rifampicin | 0.568 (0.015) | ||||
| Tetracyclin | 0.527 (0.01) | | | | |
| B. Single-antimicrobial, multiple-months. | |||||
| Antimicrobial | Indicator Value (P) | February, 2011 | October, 2011 | November, 2011 | March, 2012 |
| Cephotaxime | 0.953 (0.005) | + | + | + | |
| Cefepime | 0.965 (0.005) | + | + | + | |